Morgan Stanley Raises Amgen (AMGN) Price Target Following a Strong Start for Uplizna
With an annual dividend yield of 2.85%, Amgen Inc. (NASDAQ:AMGN) is included among the 12 High Yield Fortune 500 Stocks to Buy Now. Amgen Inc. (NASDAQ:AMGN) discovers, develops, manufactures, and delivers innovative medicines to fight some of the world’s toughest diseases. On June 10, Morgan Stanley
Brief summary
What this story is about
With an annual dividend yield of 2.85%, Amgen Inc. (NASDAQ:AMGN) is included among the 12 High Yield Fortune 500 Stocks to Buy Now. Amgen Inc. (NASDAQ:AMGN) discovers, develops, manufactures, and delivers innovative medicines to fight some of the world’s toughest diseases. On June 10, Morgan Stanley
Why it matters
Reader takeaways
- Separate market commentary from official financial releases and investor materials.
- Watch for cloud revenue, AI infrastructure, capex, guidance, and customer-demand signals.
- Readers making financial decisions should rely on primary filings and professional advice.
SEO context
Topic and keyword map
This brief is filed under ORCL earnings, business, market and investor coverage.
ORCL stock newsOracle earningsOracle revenueOracle investor relationsAI infrastructure demand